Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Pamiparib

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ivy Brain Tumor Center Announces Initial Results of Pamiparib Newly-Diagnosed
    Ivy Brain Tumor Center Announces Initial Results of Pamiparib Newly-Diagnosed

    10 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/10/2513564/0/en/Ivy-Brain-Tumor-Center-Announces-Initial-Results-of-Pamiparib-in-Newly-Diagnosed-and-Recurrent-Glioblastoma-at-the-European-Society-for-Medical-Oncology-ESMO-2022-Congress.html

    GLOBENEWSWIRE
    10 Sep 2022
    Share Share
    BeiGene Announces Inclusion in the China National Reimbursement Drug List
    BeiGene Announces Inclusion in the China National Reimbursement Drug List

    02 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211202006057/en

    BUSINESSWIRE
    02 Dec 2021
    Share Share
    BeiGene Announces Inclusion in the China National Reimbursement Drug List (NRDL)
    BeiGene Announces Inclusion in the China National Reimbursement Drug List (NRDL)

    02 Dec 2021

    // PRESS RELEASE

    https://ir.beigene.com/news-details/?id=bd70a6d2-35e1-4fcb-a5de-cf202c9c8acc

    PRESS RELEASE
    02 Dec 2021
    Share Share
    BeiGene Announces Data on Tislelizumab & Pamiparib to at the 2020
    BeiGene Announces Data on Tislelizumab & Pamiparib to at the 2020

    05 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/05/2073149/0/en/BeiGene-Announces-Data-on-Tislelizumab-and-Pamiparib-to-Be-Presented-at-the-2020-European-Society-for-Medical-Oncology-ESMO-Virtual-Congress.html

    GLOBENEWSWIRE
    05 Aug 2020
    Share Share
    Priority Review Granted to BeiGene’s New Drug Application of Pamiparib
    Priority Review Granted to BeiGene’s New Drug Application of Pamiparib

    27 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/27/2067987/0/en/Priority-Review-Granted-to-BeiGene-s-New-Drug-Application-of-Pamiparib-in-Ovarian-Cancer-in-China.html

    GLOBENEWSWIRE
    27 Jul 2020
    Share Share
    BMS gets the ball rolling on liso-cel Europe; BeiGene files China NDA PARP drug
    BMS gets the ball rolling on liso-cel Europe; BeiGene files China NDA PARP drug

    17 Jul 2020

    // John Carroll ENDPTS

    https://endpts.com/bms-gets-the-ball-rolling-on-liso-cel-in-europe-beigene-files-china-nda-for-in-house-parp-drug/

    John Carroll ENDPTS
    17 Jul 2020
    Share Share